circSMARCA5 Functions as a Diagnostic and Prognostic Biomarker for Gastric Cancer.

Discussion: Our results demonstrated that circSMARCA5 was decreased and exerted tumor-suppressive effects in GC. circSMARCA5 can function as a potential biomarker for GC prognosis and diagnosis. PMID: 30956729 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30956729?dopt=Abstract

Source: Disease Markers - April 9, 2019 Category: Laboratory Medicine Tags: Dis Markers Source Type: research